Società biOasis Technologies Inc Toronto S.E.
Azioni
BTI
CA09064N1033
Biotecnologia
Attività
Vendite per attività
CAD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Diagnosis and Treatment of Neurological Diseases and Disorders
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07% |
Vendite per regione
CAD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -99,07% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 21/09/17 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 01/07/21 |
Mei Mei Tian
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/12 |
Graeme Dick
IRC | Investor Relations Contact | - | 01/11/11 |
Christopher Lowe
SEC | Corporate Secretary | 56 | 03/10/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
John Hemeon
BRD | Director/Board Member | 59 | - |
David Wurzer
BRD | Director/Board Member | 65 | 27/07/18 |
Deborah Rathjen
CEO | Chief Executive Officer | - | 21/09/17 |
Director/Board Member | 63 | 01/06/18 | |
John E. Curran
BRD | Director/Board Member | - | 27/07/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 79 414 015 | 77 784 778 ( 97,95 %) | 0 | 97,95 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,53% | 45,51 Mrd | |
-9,85% | 38,52 Mrd | |
+38,08% | 38,13 Mrd | |
+27,32% | 30,74 Mrd | |
-8,64% | 26,03 Mrd | |
+11,69% | 25,92 Mrd | |
+45,53% | 14,13 Mrd | |
+33,37% | 12,73 Mrd | |
-7,69% | 11,29 Mrd |